Novo Integrated Sciences, Inc. (NVOS)

Novo Integrated Sciences Revenue

Novo Integrated Sciences had revenue of $13.66M in the twelve months ending February 29, 2024, with 16.91% growth year-over-year. Revenue in the quarter ending February 29, 2024 was $3.17M with 24.02% year-over-year growth. In the fiscal year ending August 31, 2023, Novo Integrated Sciences had annual revenue of $12.57M with 7.11% growth.

• Revenue (ttm): $13.66M
• Revenue Growth: +16.91%
• P/S Ratio: 1.20
• Revenue / Employee: $107,544
• Employees: 127
• Market Cap: 16.46M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2023	12.57M	834.08K	7.11%
Aug 31, 2022	11.74M	2.43M	26.14%
Aug 31, 2021	9.31M	1.44M	18.38%
Aug 31, 2020	7.86M	-1.56M	-16.57%
Aug 31, 2019	9.42M	527.36K	5.93%
Aug 31, 2018	8.89M	931.42K	11.70%
Aug 31, 2017	7.96M	784.80K	10.93%
Aug 31, 2016	7.18M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.